Market Closed

BRVE
Braveheart Bio
$ 19.62
-4.29%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago

Braveheart Bio News

Latest Braveheart Bio Stock News & BRVE Headlines

Braveheart Bio, Inc. (BRVE) Shareholder/Analyst Call Transcript
9 days ago | seekingalpha.com
Braveheart Bio Shares One-Year Heart Drug Data, Plans New Fixed-Dose Trial
9 days ago | marketbeat.com
Braveheart Bio Announces Upcoming Presentations at the American Heart Association Scientific Sessions 2026
16 days ago | globenewswire.com
Braveheart Bio (NASDAQ:BRVE) Stock Falls 7.3% – Here’s What Happened
a month ago | defenseworld.net
Braveheart Bio to Participate in Stifel Cardiometabolic Forum
2 months ago | globenewswire.com
Braveheart Bio Reports Second Quarter 2026 Financial Results and Provides Business Update
2 months ago | globenewswire.com
Braveheart Bio to Participate in Cantor Global Healthcare Conference
2 months ago | globenewswire.com
Braveheart Bio CFO Acquires 27,777 Shares for $500,000. Is This a Signal BRVE IPO Is a Success?
3 months ago | fool.com
Braveheart Bio Chairman Chris Viehbacher Buys $1.5M Shares at IPO. What Does This Mean for Investors?
3 months ago | fool.com
Braveheart Bio CEO Travis Murdoch Buys 83,333 Shares for $1.5 Million. Is This a Buy Signal for Investors?
3 months ago | fool.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

BRVE
Braveheart Bio
$ 19.62
-4.29%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago